MA Okezue, C Uche, A Adebola, SR Byrn - AAPS PharmSciTech, 2024 - Springer
Bedaquiline (BQ) solid lipid nanoparticles (SLNs), which have previously been formulated
for parenteral administration, have a risk of patient non-compliance in treating tuberculosis …